GE HealthCare Files 8-K: Other Events & Exhibits

Ticker: GEHC · Form: 8-K · Filed: 2025-06-04T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, sec-filing, corporate-event

Related Tickers: GEHC

TL;DR

GE HealthCare filed an 8-K for 'Other Events' and exhibits on June 3rd.

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on June 4, 2025, reporting an event that occurred on June 3, 2025. The filing indicates a change in the company's structure or operations, as it is listed under 'Other Events' and includes 'Financial Statements and Exhibits'. Specific details of the event are not elaborated in the provided text, but it signifies a formal disclosure to the SEC.

Why It Matters

This filing indicates GE HealthCare is making a material disclosure to the SEC, which could involve significant business updates or financial reporting.

Risk Assessment

Risk Level: low — The filing is a standard disclosure and does not contain information suggesting immediate risk.

Key Numbers

Key Players & Entities

FAQ

What specific event is GE HealthCare Technologies Inc. reporting under 'Other Events'?

The provided text does not specify the exact nature of the 'Other Events' beyond indicating it is a reportable event requiring an 8-K filing.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 3, 2025.

What is the SEC file number for GE HealthCare Technologies Inc.?

The SEC file number for GE HealthCare Technologies Inc. is 001-41528.

Where are GE HealthCare Technologies Inc.'s principal executive offices located?

The principal executive offices of GE HealthCare Technologies Inc. are located at 500 W. Monroe Street, Chicago, IL 60661.

What is the significance of filing an 8-K form?

An 8-K form is used by publicly traded companies to disclose material events that shareholders should know about, such as acquisitions, bankruptcy, or changes in executive management.

From the Filing

0001932393-25-000039.txt : 20250604 0001932393-25-000039.hdr.sgml : 20250604 20250604165031 ACCESSION NUMBER: 0001932393-25-000039 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250603 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250604 DATE AS OF CHANGE: 20250604 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 251023812 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 gehc-20250603.htm 8-K gehc-20250603 0001932393 false 0001932393 2025-06-03 2025-06-03 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 3, 2025 GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)   Delaware 001-41528 88-2515116 (State or other jurisdiction of incorporation) (Commission  File Number) (IRS Employer Identification No.)       500 W. Monroe Street, Chicago, IL   60661 (Address of principal executive offices)   (Zip Code)         (Registrant’s telephone number, including area code) ( 833 ) 735-1139 ______________________________________________ (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01 Other Events. On June 3, 2025, GE HealthCare Technologies Inc. (the “Company”) commenced and priced an underwritten offering (the “Offering”) of $650,000,000 aggregate principal amount of 4.800% Notes due January 15, 2031 (the “2031 Notes”) and $850,000,000 aggregate principal amount of 5.500% Notes due June 15, 2035 (the “2035 Notes” and, together with the 2031 Notes, the “Notes”) pursuant to the registration statement on Form S-3 (File No. 333-280584), filed with the Securities and Exchange Commission on June 28, 2024. The Notes are expected to be issued on or arou

View on Read The Filing